# INmune Bio Inc. (INMB): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for INmune Bio Inc. (INMB) is 23/100, ranked against 24,000+ stocks in 35 markets (Quality 23, Value 30, Momentum 54, each scored against its sector).

- StockRank: 23/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 23, Value 30, Momentum 54: each a 0-100 percentile within Healthcare.
- Position: #20,365 overall, #1,818 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 1.43 USD on 26 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/INMB
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker